体外診断用医薬品の世界市場2016-2026...市場調査レポートについてご紹介

1. Report Overview
1.1 Introduction to the IVD Industry and Market
1.2 Main Report Findings
1.3 This Study Provides the Following Knowledge
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Main Questions Answered by This Study
1.7 Who is This Study For?
1.8 Research Methods and Analysis
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. Introduction
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 The US Classification
2.2.2 The European Commision (EC) Classification
2.2.3 Regulatory Issues in the IVD Market
2.2.3.1 Regulation of IVD Tests
2.2.3.2 Lack of Clarity Can be Costly
2.3 What are the Different Types of IVD Tests?
2.3.1 Point of care Diagnostics – The Most Prominent Type of IVD
2.3.2 Clinical Chemistry is Increasing in Complexity
2.3.3 Microbiology
2.3.3.1 Regulatory Differences with IVD Microbiology Tests
2.3.4 Haematology
2.3.5 Immunochemistry
2.3.6 Genetic Testing

3. The Global In Vitro Diagnostics Market, 2016-2026
3.1 In Vitro Diagnostics Market in 2015
3.2 Global IVD Market Forecast, 2016-2026: Three Submarkets Dominate
3.3 Expected IVD Industry Trends Over 2016-2026
3.3.1 Advances in Technology Driving the IVD Market
3.3.2 A Shift towards Decentralisation Healthcare
3.3.3 Increased Awareness of the Need for IVD Tests

4. In Vitro Diagnostics Submarkets, 2016-2026
4.1 The Global Point-of-Care IVD Market, 2016-2026: A Revolution in the Making
4.1.1 POC Diagnostics Market, 2015
4.1.2 POC Diagnostics: Market Forecast, 2016-2026
4.1.3 POC Diagnostics: Market Trends, 2016-2026
4.1.3.1 New Tests Targeting Biomarkers Will Be Crucial
4.1.3.2 Competition Driving Consolidation and Product Innovation
4.1.3.3 Infectious Diseases Prompting Growth of POC
4.1.3.4 Other Factors Influencing the POC Segment
4.2 The Global Clinical Chemistry IVD Market, 2016-2026
4.2.1 Clinical Chemistry Market Forecast, 2016-2026
4.2.2 Clinical Chemistry Market Trends, 2016-2026
4.3 The Global Immunochemistry IVD Market, 2016-2026
4.3.1 Immunochemistry Market Forecast, 2016-2026
4.3.2 Immunochemistry Market Trends, 2016-2026
4.3.2.1 Immunoassays and Automated Systems Prompting Market Growth
4.3.2.2 Emerging Markets Showing Strong Growth and Opportunities
4.4 The Global Haematology IVD Market, 2016-2026
4.4.1 Haematology Market Forecast, 2016-2026
4.4.2 Haematology Market Trends, 2016-2026
4.5 The Global Microbiology IVD Submarket, 2016-2026
4.5.1 Microbiology Market Forecast, 2016-2026
4.5.2 Microbiology Market Trends, 2016-2026
4.6 Genetic testing – The Future of the Industry
4.6.1 Genetic Testing Market Forecast, 2016-2026
4.6.2 Genetic Testing Market Trends, 2016-2026
4.6.2.1 Cytogenetic tests to Drive Market Growth
4.6.2.2 Direct-To-Consumer (DTC) Genetic Screening
4.6.2.3 Theranostics: Targeting Unmet Needs through DNA Tests

5. Leading National IVD Markets, 2016-2026
5.1 Regional Breakdown of the Global IVD Market, 2015
5.2 Leading National Markets for the Global IVD Market, 2016-2026
5.3 The US IVD Market Forecast, 2016-2026: Still the Global Leader
5.3.1 Increased Levels of Molecular Testing in the US
5.3.2 Increased Use of Mobile Applications
5.3.3 Obamacare and the Medical Device Excise Tax
5.4 The Japanese IVD Market 2016-2026
5.5 The EU5 Nations IVD Market, 2016-2026
5.5.1 Germany IVD Market, 2016-2026
5.5.2 The French IVD Market, 2012-2026
5.5.3 The UK IVD Market, 2016-2026
5.5.4 The Spanish IVD Market, 2016-2026
5.5.5 The Italian IVD Market, 2016-2026
5.6 The BRIC Nations
5.6.1 The Brazilian IVD Market, 2016-2026
5.6.2 The Russian IVD Market, 2016-2026
5.6.3 The Indian IVD Market, 2016-2026
5.6.4 The Chinese IVD Market, 2016-2026

6. Leading Companies in the IVD Market, 2016
6.1 A Fragmented Market with a Few Dominant Major Players
6.2 IVD Market Leaders Breakdown
6.3 Roche Continues to Dominate
6.3.1 Sales and Recent Performance Analysis, 2015
6.3.1.1 Roche Diagnostics – Driven by Immunodiagnostic Products
6.4 Danaher – A Strong Competitor in the IVD Market
6.4.1 Sales and Performance Analysis, 2015
6.4.1.1 Life sciences & Diagnostics – Danaher’s Main Source of Revenue
6.5 Siemens – A Highly Diversified Company
6.5.1 Sales and Recent Performance Analysis
6.5.1.1 Siemens Healthcare Sector
6.6 Abbott Laboratories Make a Prominent Contribution
6.6.1 Sales and Recent Performance Analysis, 2015
6.6.1.1 The Abbott Diagnostics Segment – Alere Acquisition Proving Troublesome
6.7 Thermo Fisher Scientific Acquires Life Technologies
6.8 Agilent Technologies Inc.
6.9 Smaller Companies in the IVD Market, 2016
6.9.1 Johnson & Johnson – The World’s Largest Med Tech Company
6.9.2 Myriad Genetics – Specialist Molecular Diagnostics
6.9.3 Horizon Discovery – A World Leader in Gene-Editing

7. SWOT and STEP Analysis of the IVD Market, 2016
7.1 In Vitro Diagnostics: Industry Trends
7.2 Strengths of the IVD Market, 2016
7.2.1 Patient Demographics Will be a Major Driver
7.2.2 Innovation Will Continue
7.3 Weaknesses
7.3.1 Regulatory Board Approvals May be Problematic
7.3.2 Reimbursement Issues Could Restrain Growth
7.4 Opportunities
7.4.1 Globalisation Creates a Wealth of Opportunity in Emerging Economies
7.4.2 Molecular Diagnostics Will have Increased Prominence
7.5 Threats
7.5.1 Medical Device Excise Tax in the US
7.5.2 Convergence
7.6 STEP Analysis
7.6.1 Social Factors
7.6.2 Technological Factors
7.6.3 Economic Factors
7.6.4 Political Factors

8. Research Interviews
8.1 Interview with Horizon Discovery, a Gene-Editing Company
8.1.1 On Horizon Discovery and the IVD Products Which They Offer
8.1.2 On the Challenges of Developing IVDs
8.1.3 On IVDs in the Future

9. Conclusions from the Research
9.1 Overview of the IVD Market
9.2 Submarket Breakdown: Point of Care Testing Will be the Biggest Driver
9.3 National IVD Market Outlook, 2016-2026
9.4 Leading Companies in the Global IVD Market
9.5 Future Outlook and Concluding Remarks
9.6 Associated Visiongain Reports
9.7 Visiongain Report Sales Order Form
9.8 About Visiongain
9.9 Report Evaluation Form